From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 18,227,779 shares, representing 25.26% for $588.23 million under the buyback announced on November 5, 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.62 USD | -0.16% |
|
+3.01% | +28.63% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.63% | 2.23B | |
-8.90% | 11.53B | |
-12.79% | 7.33B | |
+26.65% | 5.68B | |
-17.87% | 3.71B | |
+7.41% | 2.49B | |
-65.15% | 2.35B | |
-11.56% | 2.22B | |
-14.32% | 1.61B | |
-9.41% | 1.36B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Tranche Update on Myriad Genetics, Inc.'s Equity Buyback Plan announced on November 5, 2013.